[Efficacy and safety of pancrealipase delayed-release capsules (Creon) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery].
In the article design, objectives, methods of conducting double-blind, randomized study which results prove efficacy and safety of new formulation of Creon are presented.
Vitkomb
D
D
Maleska-Panas
E
E
Lekhman
G
G
Vasil'eva
N
N
Gubergrits
N
N
Karas
S
S
Shen
Ia
Ia
Sander-Strukmaer
S
S
D000328:Adult; D004311:Double-Blind Method; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism / Q000601:surgery*; D050500:Pancreatitis, Chronic / Q000378:metabolism / Q000628:therapy*; D020799:Pancrelipase / Q000008:administration & dosage* / Q000009:adverse effects
D005765:Gastrointestinal Agents; D020799:Pancrelipase